Posted on 9月 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on 8月 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on 7月 16, 20247/16/24
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Posted on 6月 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 4月 16, 20244/16/24
Navigating Pharmaceutical Success: Harnessing Data Analytics and Predictive Modeling
Posted on 1月 3, 20241/3/24
Transforming Pharmaceutical Commercialization: Eight Key Insights for Success
Posted on 11月 15, 202311/15/23
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
Posted on 8月 21, 20238/21/23